Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation

(2009) Y. Hiruma et al.   BLOOD

Role of decorin in the antimyeloma effects of osteoblasts

(2008) X. Li et al.   BLOOD

Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth

(2008) Y.-W. Qiang et al.   BLOOD

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma

(2008) Martin Kaiser et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment

(2008) Ulrike Heider et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells

(2008) Donatella Granchi et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma

(2008) Deborah J Heath et al.   JOURNAL OF BONE AND MINERAL RESEARCH